ESR1 and neoplasm: For instance, a patient with a tumor classified as T2, G3, ER+, PR+, and HER− is predicted to have a 5-year disease-free survival with a likelihood of 85% if the preoperative CA27.29 level was low and a likelihood of 75% if the preoperative CA27.29 was high.